Evidence map›Paper›PMID 30445507›Full record

Trial reportTranslational behavioral medicine2019

Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness.

Roger Vilardaga, Javier Rizo, Richard K Ries, Julie A Kientz, Douglas M Ziedonis, Kayla Hernandez, Francis J McClernon

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational behavioral medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 5 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 5 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  12. Article
  13. Article
  14. Article
  15. Case Reports in the Integration of Technology with Cognitive Rehabilitation for Individuals with Memory Concerns and Their Care Partners.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Roger VilardagaDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
Javier RizoDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
Richard K RiesDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
Julie A KientzDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
Douglas M ZiedonisDepartment of Psychiatry, University of California, San Diego, San Diego, CA, USA.
Kayla HernandezDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
Francis J McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
Duke University · USUniversity of Washington · USUniversity of California San Diego · US

Funding

Innovative Smartphone Application for Quitting Smoking among Seriously Mentally IIIR00DA037276 · NIDA · DUKE UNIVERSITY · PI VILARDAGA, ROGER · 2016 to 2018
$747k
Innovative Smartphone Application for Quitting Smoking among Seriously Mentally IK99DA037276 · NIDA · UNIVERSITY OF WASHINGTON · PI VILARDAGA, ROGER · 2014 to 2015
$344k
NIDA NIH HHS K99 DA037276NIDA NIH HHS R00 DA037276
6 · The paper itself

Abstract

Despite public health efforts, individuals with serious mental illness (SMI) still have very high rates of tobacco smoking. Innovative approaches to reach this population are needed. These series of case studies aimed to descriptively evaluate the usability, user experience (UX), and user engagement (UE) of Learn to Quit (LTQ), an acceptance and commitment therapy smoking cessation app designed for people with SMI, and to compare it with an app designed for the general population, NCI (National Cancer Institute) QuitGuide (QG). Both apps were combined with nicotine replacement therapy and technical coaching. Inspired by the ORBIT model, we implemented two case studies with crossover AB interventions, two B-phase training designs, and three bi-phasic AB single-case designs with Start-Point and Order randomization (A = QG, B = LTQ). Study outcomes were measured using the System Usability Scale, UX interviews, and background analytics. LTQ's usability levels were above the standard cutoff and on average higher than QG. UX outcomes suggested the relative benefits of LTQ's visual design, gamification and simple design structure. LTQ's overall UE was high; the app was opened for an average of 14 min per day (vs. QG: 7 min). However, users showed low levels of UE with each of the app's tracking feature. Measures of psychiatric functioning suggested the safety of LTQ in people with SMI. LTQ appears to be a usable and engaging smoking cessation app in people with SMI. An optimized version of LTQ should be tested in a Phase II study.

Indexed as

Acceptance and Commitment TherapyMental DisordersMobile ApplicationsPatient Outcome AssessmentSmoking CessationTelemedicineAdultComorbidityFemaleHumansMaleMiddle AgedSmokingAcceptance and commitment therapyCase studiesmHealthSerious mental illnessSmoking cessationUser experience

Identifiers

PMID30445507
PMCPMC7184916
OpenAlexW2901202149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.